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Pranscatheter Cryoablation
f Tachyarrhythmias in Children
nitial Experience From an International Registry
oel A. Kirsh, MD, FRCP(C), FACC,* Gil J. Gross, MD, FRCP(C), FACC,* Stephen O’Connor, PHD,†
obert M. Hamilton, MD, FRCP(C),* for the Cryocath International Patient Registry
ntario and Quebec, Canada
OBJECTIVES We sought to describe the early pediatric experience of transcatheter cryoablation, and
identify whether specific arrhythmia substrates and/or ablation locations were particularly
suited to cryoablation.
BACKGROUND Radiofrequency (RF) ablation has become established therapy for pediatric tachyarrhythmias.
However, challenges remain in terms of the safety and efficacy of RF ablation in specific
locations; new methods may address these issues.
METHODS Prospective data were available for 64 patients age 13  4 (mean  SD) years undergoing
cryoablation at 14 centers participating in the Cryocath International Patient Registry.
Dysrhythmia duration was 5.0 4.2 years, with diagnoses of atrioventricular node re-entrant
tachycardia (AVNRT) (n  30), anteroseptal (n  11), midseptal (n  5), or other (n  15)
accessory pathway (AP) mediated AV re-entry, ventricular tachycardia (VT) (n  3), and
ectopic atrial tachycardia (EAT) (n  2). Two patients had more than one arrhythmia
substrate. Transcatheter cryoablation was offered by cardiologist preference after written
informed procedural consent of each patient and/or legal guardian. Cryomapping was
performed at 30°C and cryoablation was delivered with 4-min applications at 75°C.
RESULTS Acute success was achieved in 45 of 65 (69%) cryoablation patients, with best success rates in
AVNRT (83%) and right septal AP (75%), and lower success rates in other AP (43%), VT
(66%), and EAT (0%). No device-related adverse events were reported. The success of
radiofrequency (RF) ablation applied in 14 cryoablation failures was 4 of 4 for AVNRT
patients, 1 of 1 for anteroseptal AP patients, 5 of 6 for other AP patients, 0 of 1 for VT
patients, and 0 of 2 for EAT patients.
CONCLUSIONS Transcatheter cryoablation is a safe and well-tolerated alternative to RF ablation in pediatric
patients on the basis of our initial experience. Success is highest in AVNRT and in substrates
recognized as technically challenging or risky for RF ablation. (J Am Coll Cardiol 2005;45:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.049133–6) © 2005 by the American College of Cardiology Foundation
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iadiofrequency (RF) ablation has become established ther-
py for pediatric tachyarrhythmias (1,2). However, chal-
enges remain in terms of the safety and efficacy of RF
blation in specific locations, including the potential for
njury to the coronary arteries, particularly when ablating
ithin the coronary sinus and coronary veins (3–14). There
ontinues to be a significant risk of ablation-induced atrio-
entricular (AV) block (15), particularly in right septal
ocations (16). The right AV groove may be a difficult
ocation to achieve adequate catheter contact and stability,
esulting in disappointing ablation results (17). Recently,
ranscatheter cryoablation delivery systems appropriate for
ediatric use have been developed (18–23).
We sought to evaluate the safety and efficacy of early
ediatric experience of transcatheter cryoablation as re-
orded in a prospective multicenter cryoablation procedure
egistry, as well as attempting to identify whether specific
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eceived, in the past, both travel support and honoraria from Cryocath Inc. Dr.
’Connor is a former employee of Cryocath Inc.r
Manuscript received June 21, 2004; revised received October 14, 2004, accepted
ctober 18, 2004.rrhythmia substrates and/or ablation locations were partic-
larly suited to this new method.
ETHODS
rospective data collection was performed for all patients
18 years of age undergoing a transcatheter cryoablation
rocedure using a Cryocath (Kirkland, Canada) system.
here were 14 centers in 8 countries, all participating in the
ryocath International Patient Registry. Cryoablation was
ffered by physician preference, in most cases based on
ubstrate location, with informed consent after local regu-
atory approval. Outcome measures were determined as for
F ablation.
After standard electrophysiologic assessment, a 7-F
ryoablation catheter (Freezor 4 mm tip or Freezor Xtra
mm tip, CryoCath) was introduced via femoral (62
atients) and/or other (5 patients) venous and/or femoral
rterial (1 patient) access. Cryomapping at 30°C for up
o 60 s was performed and the arrhythmic substrate
e-evaluated. Catheter adherence to the endocardium
uring the cryomap allowed for extrastimulus testing for
nducibility, or in the case of atrioventricular nodal
e-entrant tachycardia (AVNRT), assessment of slow
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or a 4-min period.
ESULTS
here were 66 cryoablation attempts in 64 patients (36
ales) age 1 to 18 years (mean  SD, 13  4 years). Two
atients had dual substrates. One patient had congenital
eart disease, with a previous repair of tetralogy of Fallot.
The distribution of arrhythmia substrates, as well as the
rocedural times and fluoroscopy times, stratified by sub-
trate, are shown in Table 1. Procedural data were unavail-
ble for one of the ectopic atrial tachycardia (EAT) cases.
hirty of the 66 cryoablations were for AVNRT. There
ere 30 cryoablations of accessory pathways (APs), one-half
f which were right anteroseptal or midseptal.
The number of cryomaps and cryoablations, stratified by
uccess and failure, is reported in Table 2. Although there
ppears to be a trend toward higher mean numbers of maps
nd ablations in failed attempts, the distributions are
kewed and the medians are not dissimilar (p  NS by
ank-sum test).
Best success rates (Table 1) were seen in AVNRT (83%)
nd right septal accessory pathways (75%), with lower
uccess rates in other APs (43%) and ventricular tachycardia
VT) (66%). There were no reported successes in cryoabla-
ion of EAT, although the denominator is only two.
We evaluated the fate of failed cryoablation attempts
Table 1). Of the five failures of cryoablation in AVNRT,
our were successfully treated by RF ablation. Of the four
ailed cryoablations of anteroseptal and midseptal APs,
hree were abandoned at the discretion of the clinician, and
ne anteroseptal AP was successfully RF ablated. Of the
Abbreviations and Acronyms
AP  accessory pathway
AV  atrioventricular
AVNRT  atrioventricular nodal re-entrant tachycardia
AVRT  atrioventricular re-entrant tachycardia
EAT  ectopic atrial tachycardia
EP  electrophysiologic
RF  radiofrequency
VT  ventricular tachycardia
able 1. Cryoablation Procedure Details
Substrate N
Procedure
Mean  SD
(min)
Fluoroscopy
Mean  SD
(min)
VNRT 30 168  51 17  10
nteroseptal AP 11 184  64 40  34
idseptal AP 5 215  70 46  47
ther AP 14 230  94 35  19
T 3 195  96 21  12
AT 2* 75  0* 5  0*Data not available for 1 EAT ablation case. In several cases of failed cryoablation, radiofr
AP  accessory pathway; AVNRT  atrioventricular nodal re-entrant tachycardia; EATight failed cryoablations for other APs, three were in the
ight posterior septum, two in the left posterior septum, one
ithin the coronary sinus, and two on the left free wall. Two
f these cases were abandoned, and five of the six remaining
Ps were successfully ablated with RF. All of the failed VT
r EAT cryoablations also failed RF ablation.
From the patient’s point of view in this series, the
rocedural success rate for ablation of AVNRT or AP, from
ny energy source, was 97% for AVNRT and 80% to 86%
or APs, most of which were in right septal locations.
dverse events. There were no complications of electro-
hysiologic (EP) study or cryoablation, specifically no cardio-
ascular injury and no permanent AV block. During cryomap-
ing, transient observations of AV conduction abnormalities
anging from first degree AV delay to complete heart block
ere anecdotally observed, particularly in right septal locations;
ll of these were immediately reversed upon rewarming. One
dverse event of “prolonged hospitalization due to prostatitis”
as of uncertain relationship to the initial procedure. By way of
omparison, a 3% to 4% overall complication rate for EP study
nd RF ablation has been shown in the Prospective Assess-
ent after Pediatric Cardiac Ablation (PAPCA) study and its
ssociated registry (17), whereas the reported incidence of AV
lock caused by RF ablation is 1.2% for AVNRT and 3.6% for
ll right septal pathways (24). In a review of a single center’s
xperience of 145 septal APs, four cases of permanent AV
lock in 47 attempted anteroseptal and midseptal ablations
ere observed, for a site-specific AV block rate of 8.5% (16).
ollow-up. Three-month follow-up data were available for
8 of the 45 acutely successful cryoablations. There were
our reported recurrences: two of AV node re-entry, one
osteroseptal AP, and one VT. Depending on which
enominator one uses, this may suggest somewhere between
% and 14% recurrence rates. Because the follow-up data
re incomplete, a selection bias to follow-up in the recur-
ence patients would be a reasonable assumption, and thus
he recurrence rate may not be dissimilar from the PAPCA
xperience of 7% and 9% at two and six months, respectively
25).
ISCUSSION
fficacy and safety. This report represents the initial pe-
iatric experience (as recorded in an international registry)
Cryo
Success
N (%)
Cryo
Failure
N (%)
RF Success
N of N
Attempts
Combined
Success, %
25 (83%) 5 (17%) 4 of 4 97%
8 (73%) 3 (27%) 1 of 1 82%
4 (80%) 1 (20%) 0 of 0 80%
6 (43%) 8 (57%) 5 of 6 86%
2 (67%) 1 (33%) 0 of 1 67%
0 (0%) 2 (100%) 0 of 2 0%equency ablation was not attempted.
 ectopic atrial tachycardia; RF  radio frequency; VT  ventricular tachycardia.
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January 4, 2005:133–6 Cryoablation of Arrhythmias in Childrenf the use of a novel transcatheter cryoablation system.
cute success rates of 83% and 75% for AVNRT and right
eptal APs are similar to those of the early era of the
ediatric RF ablation experience (1,26). Most impressively,
here were no reports of injury to the normal conduction
ystem, a finding similar to the larger adult experience with
his form of ablation energy (27,28). Although the
ollow-up data in the Cryoablation Registry are incomplete,
he recurrence rates are not dissimilar to those seen after RF
blations.
cute failure of cryoablation. Although there were less
mpressive acute success rates in posteroseptal and free wall
ocations, most of these pathways were subsequently suc-
essfully ablated using RF energy, suggesting that lesion size
nd delivery may have played a role in these locations
29,30). In contrast, the failure of RF ablation following
ttempted cryoablation of VT and EAT suggests that the
blation energy source and mode of delivery were not
esponsible in these cases.
nique features of cryoablation. The reversibility of cryo-
apping provides the opportunity for forgivable test lesions
n locations known to be at high risk for heart block during
mpiric RF ablation. Accompanying this is the ability to
ormally retest AV nodal physiology as well as arrhythmia
nducibility during both cryomapping and cryoablation (28).
he intrinsic catheter stability related to cryoadhesion
revents dislodgement during ablation. All of these charac-
eristics are expected to enhance both safety and efficacy
27,31,32).
ssues remaining to be resolved. The disappointing per-
ormance during this early cryoablation experience in the
blation of some APs is most likely related to the smaller
esion size with initial versions of the cryoablation catheter,
eading to a smaller effective target area being ablated. The
ssue of convective heat loss during cryoablation on the atrial
ide of the left AV groove has been suggested as playing a
ole (30), with some centers reporting better success when
sing a retrograde approach in adults, although the safety
nd efficacy of a retrograde approach with the relatively stiff
ryoablation catheter has not been evaluated in children
Dr. M. Dubuc, personal communication, March 2003).
ewer cryoablation catheters with larger tip surface areas
nd/or modified coolant gas parameters may offer a benefit
n these situations.
Similar to the early experience with RF ablation (26), it is
able 2. Cryoablation Details
# of Cryomaps
Mean  SD
Median [Range]
# of Cryoablations
Mean  SD
Median [Range]
uccess 5.6  3.2 2.9  3.3
6 [0–12] 2 [0–17]
ailure 9.1  6.8 6.4  6.7
6 [2–22] 3 [0–20]
ll pNS by rank-sum test for # of cryomaps or cryoablations, success versus failure.easonable to expect that a learning curve exists for the
1ttainment of proficiency in utilizing cryoablation. Acute
uccess rates as well as recurrence risks are currently accept-
ble, but should eventually approach those of established
odalities. The established safety of cryoablation in high-
isk locations should allow the effective ablation of arrhyth-
ias that otherwise might be abandoned, or perhaps ablated
ith a requirement for permanent pacing (16).
onclusions. Cryoablation is a safe and effective alterna-
ive to RF ablation and appears to offer unique advantages
elated to catheter stability during energy delivery, as well as
he safety of reversible mapping lesions in high-risk
ocations.
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